[
  {
    "ts": null,
    "headline": "How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative",
    "summary": "In October 2025, Biomerica announced a marketing services arrangement with Henry Schein to promote its inFoods IBS test throughout the United States, excluding New York State, utilizing Henry Schein's network of more than 400 sales representatives targeting primary care and gastroenterology practices. This collaboration highlights Henry Schein's evolving presence in precision diagnostics, following clinical evidence for the inFoods test published in a leading gastrointestinal journal showing...",
    "url": "https://finnhub.io/api/news?id=cbe437789a601cc77da0fe668b09c267def3307df34dda117cd08801cf15cc22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760660639,
      "headline": "How Biomerica Deal Expands Henry Schein’s (HSIC) Diagnostic Ambitions and Alters Its Investment Narrative",
      "id": 137122757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HSIC",
      "source": "Yahoo",
      "summary": "In October 2025, Biomerica announced a marketing services arrangement with Henry Schein to promote its inFoods IBS test throughout the United States, excluding New York State, utilizing Henry Schein's network of more than 400 sales representatives targeting primary care and gastroenterology practices. This collaboration highlights Henry Schein's evolving presence in precision diagnostics, following clinical evidence for the inFoods test published in a leading gastrointestinal journal showing...",
      "url": "https://finnhub.io/api/news?id=cbe437789a601cc77da0fe668b09c267def3307df34dda117cd08801cf15cc22"
    }
  }
]